Citius Oncology, Inc. (CTOR)

NASDAQ: CTOR · Real-Time Price · USD

0.7104

-0.0575 (-7.49%)

Oct 19, 2026, 4:00 PM EDT - Market closed

Citius Oncology Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Selling, General & Admin	45.38	17.1	15.65	7.88	2.86
Research & Development	3.39	6.42	4.93	4.24	6.86
Operating Expenses	52.79	23.52	20.57	12.12	9.71
Operating Income	-47.47	-23.52	-20.57	-12.12	-9.71
Interest Expense	-0.37	-0.22	-	-	-
Interest & Investment Income	0.21	0.04	-	-	-
Pretax Income	-45.87	-23.7	-20.57	-12.12	-9.71
Income Tax Expense	0.19	1.06	0.58	0.58	1.15
Net Income	-46.06	-24.76	-21.15	-12.7	-10.87
Net Income to Common	-46.06	-24.76	-21.15	-12.7	-10.87
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	93	73	68	68	34
Shares Outstanding (Diluted)	93	73	68	68	34
Shares Change	31.40%	7.66%	0.82%	100.00%	-
EPS (Basic)	-0.49	-0.34	-0.31	-0.19	-0.32
EPS (Diluted)	-0.49	-0.34	-0.31	-0.19	-0.32
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
EBIT	-47.47	-23.52	-20.57	-12.12	-9.71

SEC Filings: 10-K · 10-Q